Project Grant R01AG082349

Award Date 9/30/24
Completion Date 6/30/29
Dollars Obligated $763K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Hadley, MA 01035, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $230,344 Project Grant to Colorado State University under the Aging Research (CFDA 93.866) program. The grant, with a performance period from July 2024 to April 2026, aims to better understand how advancing age contributes to the development and progression of Alzheimer's disease (AD). The key objectives are to: 1) Determine how increasing endosome formation, a cellular process that declines with age, can decrease the accumulation of tau...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) is providing $780,466 to the University of Colorado-Denver to advance research on using single-channel sleep electroencephalography (EEG) as a practical digital technology for monitoring brain health and detecting early signs of neurodegenerative disease like Alzheimer's. The key products and services being delivered under this grant include: Applying advanced machine learning to a large dataset of over...
This federal Project Grant award of $999,784.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides funding to Texas A&M University System Health Science Center to conduct research on the relationship between circadian dysregulation and age-related cognitive impairment. The project, which has a performance period from February 1, 2025 to January 31, 2028, seeks to explore how disruptions in the body's internal clock may contribute to...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) will support a collaborative research study to investigate the relationship between sleep disturbances across the life course and age-related cognitive decline, including risk of Alzheimer's disease and related dementias. The $729,553 award to the Regents of the University of California, San Francisco (UCSF) will leverage data from six longitudinal cohorts,...
This $446,875 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to assess whether genetic risk variants for Alzheimer's disease have a pleiotropic effect on sleep. The study will use bioinformatic analyses to determine if causative genes for Alzheimer's disease risk also affect sleep duration and other sleep phenotypes. This in silico work will be complemented by loss-of-function studies in zebrafish models to directly evaluate the...
This Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research into the molecular interplay of sleep and neurodegeneration using the Drosophila model system. With $2.14 million provided over 11 months, the Trustees of the University of Pennsylvania will investigate how expression of the TDP-43 protein linked to neurodegenerative diseases disrupts sleep in fruit flies. Researchers will aim to define the specific glial subtypes...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $442,938 to The Regents of the University of California, San Francisco to investigate the relationship between sleep, memory formation, and age-related cognitive decline. The key objectives are to: Characterize how aging affects the sleep patterns and synaptic plasticity required for long-term memory consolidation in the C. elegans model system. Determine if upregulation of the unfolded...
The National Institute on Aging (NIA) awarded Brigham & Women's Hospital Inc. a $2,576,936 Project Grant under the Aging Research federal grant program (CFDA 93.866) to characterize the variability in sleep spindle activity across a population and evaluate the use of sleep spindle dynamics as biomarkers for Alzheimer's disease, mild cognitive impairment, and trisomy 21. The 3-year project will develop statistical models and methods to analyze sleep spindle patterns and their relationship...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Leland Stanford Junior University will provide $128,331.00 in funding to study the impact of beta-amyloid accumulation on the activity of hypocretin neurons and their role in disrupting sleep architecture in Alzheimer's disease. The overarching aim is to understand how beta-amyloid accumulation affects hypocretin neuron excitability, leading to altered homeostatic sleep pressure and the...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,498,158.00 to Synaptic Health LLC to develop a prototype device that promotes healthy sleep architecture, specifically slow wave sleep, in Alzheimer's disease patients. The goal is to create a comfortable, low-profile medical device that can sense sleep patterns and provide peripheral neuromodulation stimulation to improve sleep quality and duration, ultimately reversing the...

This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $762,733 to Colorado State University to conduct research on the relationship between neurodegenerative diseases, sleep, and circadian rhythms. The objectives are to investigate how the propagation of tau and alpha-synuclein proteins affects sleep and circadian patterns, as well as how environmental circadian disruption may impair autophagy and accelerate protein misfolding. The University of Massachusetts Amherst is a sub-awardee, contributing expertise in measuring circadian and sleep behaviors in animal models. The research aims to elucidate the bidirectional mechanisms linking neurodegenerative disease progression, sleep, and circadian clock disruption, with the goal of informing potential therapeutic interventions. The period of performance runs from September 2024 through June 2029.

Generated 4/1/25, 4:47 AM